Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy.

Sharma M, Magenheimer LK, Home T, Tamano KN, Singhal PC, Hyink DP, Klotman PE, Vanden Heuvel GB, Fields TA.

Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1127-36. doi: 10.1152/ajprenal.00475.2012. Epub 2013 Feb 6.

2.

Activation of Notch signaling pathway in HIV-associated nephropathy.

Sharma M, Callen S, Zhang D, Singhal PC, Vanden Heuvel GB, Buch S.

AIDS. 2010 Sep 10;24(14):2161-70. doi: 10.1097/QAD.0b013e32833dbc31.

3.

Role of the retinoic acid receptor-α in HIV-associated nephropathy.

Ratnam KK, Feng X, Chuang PY, Verma V, Lu TC, Wang J, Jin Y, Farias EF, Napoli JL, Chen N, Kaufman L, Takano T, D'Agati VD, Klotman PE, He JC.

Kidney Int. 2011 Mar;79(6):624-34. doi: 10.1038/ki.2010.470. Epub 2010 Dec 8.

4.

Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy.

Gu L, Dai Y, Xu J, Mallipattu S, Kaufman L, Klotman PE, He JC, Chuang PY.

AIDS. 2013 Apr 24;27(7):1091-8. doi: 10.1097/QAD.0b013e32835f1ea1.

5.

Human immunodeficiency virus downregulates podocyte apoE expression.

Arora S, Husain M, Kumar D, Patni H, Pathak S, Mehrotra D, Reddy VK, Reddy LR, Salhan D, Yadav A, Mathieson PW, Saleem MA, Chander PN, Singhal PC.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F653-61. doi: 10.1152/ajprenal.90668.2008. Epub 2009 Jun 24.

6.

Hyperglycemia enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors.

Rai P, Singh T, Lederman R, Chawla A, Kumar D, Cheng K, Valecha G, Mathieson PW, Saleem MA, Malhotra A, Singhal PC.

Cell Signal. 2015 Mar;27(3):460-9. doi: 10.1016/j.cellsig.2014.12.011. Epub 2014 Dec 24.

7.

NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy.

Ross MJ, Martinka S, D'Agati VD, Bruggeman LA.

J Am Soc Nephrol. 2005 Aug;16(8):2403-11. Epub 2005 Jun 23.

8.

Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.

Ueno T, Kobayashi N, Nakayama M, Takashima Y, Ohse T, Pastan I, Pippin JW, Shankland SJ, Uesugi N, Matsusaka T, Nagata M.

Kidney Int. 2013 Jun;83(6):1065-75. doi: 10.1038/ki.2013.48. Epub 2013 Feb 27.

9.

Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4).

Jovanovic VP, Sauer CM, Shawber CJ, Gomez R, Wang X, Sauer MV, Kitajewski J, Zimmermann RC.

Reprod Biol Endocrinol. 2013 May 15;11:43. doi: 10.1186/1477-7827-11-43.

10.

Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN.

Rai P, Plagov A, Kumar D, Pathak S, Ayasolla KR, Chawla AK, Mathieson PW, Saleem MA, Husain M, Malhotra A, Singhal PC.

Exp Mol Pathol. 2013 Feb;94(1):255-61. doi: 10.1016/j.yexmp.2012.09.009. Epub 2012 Sep 23.

11.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
12.

HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.

Yadav A, Vallabu S, Kumar D, Ding G, Charney DN, Chander PN, Singhal PC.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F734-44. doi: 10.1152/ajprenal.00415.2009. Epub 2009 Dec 16.

13.

The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.

Xie X, Colberg-Poley AM, Das JR, Li J, Zhang A, Tang P, Jerebtsova M, Gutkind JS, Ray PE.

J Am Soc Nephrol. 2014 Aug;25(8):1800-13. doi: 10.1681/ASN.2013070710. Epub 2014 Feb 27.

14.

Reduction of Stat3 activity attenuates HIV-induced kidney injury.

Feng X, Lu TC, Chuang PY, Fang W, Ratnam K, Xiong H, Ouyang X, Shen Y, Levy DE, Hyink D, Klotman M, D'Agati V, Iyengar R, Klotman PE, He JC.

J Am Soc Nephrol. 2009 Oct;20(10):2138-46. doi: 10.1681/ASN.2008080879. Epub 2009 Jul 16.

15.

HIV-1 upregulates VEGF in podocytes.

Korgaonkar SN, Feng X, Ross MD, Lu TC, D'Agati V, Iyengar R, Klotman PE, He JC.

J Am Soc Nephrol. 2008 May;19(5):877-83. doi: 10.1681/ASN.2007050629.

16.

Radiosurgery inhibition of the Notch signaling pathway in a rat model of arteriovenous malformations.

Tu J, Li Y, Hu Z, Chen Z.

J Neurosurg. 2014 Jun;120(6):1385-96. doi: 10.3171/2013.12.JNS131595. Epub 2014 Jan 10.

PMID:
24410155
17.

Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway.

Gao F, Yao M, Cao Y, Liu S, Liu Q, Duan H.

Int J Mol Med. 2016 May;37(5):1328-36. doi: 10.3892/ijmm.2016.2525. Epub 2016 Mar 11.

PMID:
26985716
18.

The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.

Xiao Z, Zhang J, Peng X, Dong Y, Jia L, Li H, Du J.

Int J Biochem Cell Biol. 2014 Oct;55:65-71. doi: 10.1016/j.biocel.2014.08.009. Epub 2014 Aug 20.

PMID:
25150830
19.

Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.

Gao J, Xiong Y, Wang Y, Wang Y, Zheng G, Xu H.

Int J Oncol. 2016 Jan;48(1):329-37. doi: 10.3892/ijo.2015.3221. Epub 2015 Oct 30.

PMID:
26530164
20.

The homophilic adhesion molecule sidekick-1 contributes to augmented podocyte aggregation in HIV-associated nephropathy.

Kaufman L, Yang G, Hayashi K, Ashby JR, Huang L, Ross MJ, Klotman ME, Klotman PE.

FASEB J. 2007 May;21(7):1367-75. Epub 2007 Feb 16.

PMID:
17307840

Supplemental Content

Support Center